Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand

Anderson, 1995, Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers, Ann. Intern. Med., 123, 771, 10.7326/0003-4819-123-10-199511150-00005 Blum, 1984, Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucin into Plasmodium falciparum grown in vitro in human erythrocytes, J. Protozool., 31, 475, 10.1111/j.1550-7408.1984.tb02997.x De Vries, 1999, Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence, Trop. Med. Int. Health, 4, 407 Divo, 1985, Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in vitro, Antimicrob. Agents Chemother., 27, 21, 10.1128/AAC.27.1.21 Foulds, 1990, The pharmacokinetics of azithromycin in human serum and tissues, J. Antimicrob. Chemother., 25, 73, 10.1093/jac/25.suppl_A.73 Gingras, 1992, Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro, Am. J. Trop. Med. Hyg., 47, 378, 10.4269/ajtmh.1992.47.378 Litchfield, 1949, A simplified method of evaluating dose–effect experiments, J. Pharmac. Exp. Ther., 96, 99 Na-Bangchang, 1996, Activity of artemether–azithromycin versus artemether–doxycycline in the treatment of multiple drug resistant falciparum malaria, Southeast Asian J. Trop. Med. Public Health, 27, 522 Noedl, H., Wernsdorfer, W.H., Krudsood, S., Wilairatana, P., Viriyavejakul, P., Kollaritsch, H., Wiedermann, G., Looareesuwan, S., 2001. An in vivo–in vitro model for the assessment of clinically relevant antimalarial cross-resistance. Am. J. Trop. Med. Hyg. in press. Ringwald, 1999, In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon, Am. J. Trop. Med. Hyg., 61, 187, 10.4269/ajtmh.1999.61.187 Taylor, 1999, Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia, Clin. Infect. Dis., 28, 74, 10.1086/515071 World Health Organisation (WHO), 1990. In vitro micro-test (Mark II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine. WHO document MAP/87.2, Rev. 1. Ye, 1994, Interaction of artemisinin and tetracycline or erythromycin against Plasmodium falciparum in vitro, Parasite, 1, 211, 10.1051/parasite/1994013211 Yeo, 1995, Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro, Int. J. Parasitol., 25, 531, 10.1016/0020-7519(94)00119-9